Regeneron's Inmazeb Becomes First Ebola Treatment To Get FDA Approval
The United States Food and Drug Administration approved Regeneron Pharmaceuticals, Inc's (NASDAQ: REGN) drug Inmazeb for the treatment of Ebola in both adults and children on Wednesday.
